FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978183755> ?p ?o ?g. }

• W1978183755 endingPage "1676" @default.
• W1978183755 startingPage "1668" @default.
• W1978183755 abstract "PURPOSE: Preclinical studies have shown good anticancer activity following targeting of a polymer bearing doxorubicin with galactosamine (PK2) to the liver. The present phase I study was devised to determine the toxicity, pharmacokinetic profile, and targeting capability of PK2. PATIENTS AND METHODS: Doxorubicin was linked via a lysosomally degradable tetrapeptide sequence to N-(2-hydroxypropyl)methacrylamide copolymers bearing galactosamine. Targeting, toxicity, and efficacy were evaluated in 31 patients with primary (n = 25) or metastatic (n = 6) liver cancer. Body distribution of the radiolabelled polymer conjugate was assessed using gamma-camera imaging and single-photon emission computed tomography. RESULTS: The polymer was administered by intravenous (IV) infusion over 1 hour, repeated every 3 weeks. Dose escalation proceeded from 20 to 160 mg/m2 (doxorubicin equivalents), the maximum-tolerated dose, which was associated with severe fatigue, grade 4 neutropenia, and grade 3 mucositis. Twenty-four hours after administration, 16.9% ± 3.9% of the administered dose of doxorubicin targeted to the liver and 3.3% ± 5.6% of dose was delivered to tumor. Doxorubicin-polymer conjugate without galactosamine showed no targeting. Three hepatoma patients showed partial responses, with one in continuing partial remission 47 months after therapy. CONCLUSION: The recommended PK2 dose is 120 mg/m2, administered every 3 weeks by IV infusion. Liver-specific doxorubicin delivery is achievable using galactosamine-modified polymers, and targeting is also seen in primary hepatocellular tumors." @default.
• W1978183755 created "2016-06-24" @default.
• W1978183755 creator A5000790552 @default.
• W1978183755 creator A5016030391 @default.
• W1978183755 creator A5018396152 @default.
• W1978183755 creator A5018823440 @default.
• W1978183755 creator A5032131181 @default.
• W1978183755 creator A5035278067 @default.
• W1978183755 creator A5038254746 @default.
• W1978183755 creator A5064892508 @default.
• W1978183755 creator A5070651503 @default.
• W1978183755 creator A5079010924 @default.
• W1978183755 date "2002-03-15" @default.
• W1978183755 modified "2023-10-17" @default.
• W1978183755 title "Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin" @default.
• W1978183755 cites W1493832020 @default.
• W1978183755 cites W1554604124 @default.
• W1978183755 cites W1582499160 @default.
• W1978183755 cites W1586481015 @default.
• W1978183755 cites W1599588465 @default.
• W1978183755 cites W1757780285 @default.
• W1978183755 cites W1871308790 @default.
• W1978183755 cites W1943022745 @default.
• W1978183755 cites W1967816890 @default.
• W1978183755 cites W1971042260 @default.
• W1978183755 cites W1978345734 @default.
• W1978183755 cites W1982690252 @default.
• W1978183755 cites W1988030050 @default.
• W1978183755 cites W1996701312 @default.
• W1978183755 cites W2028123307 @default.
• W1978183755 cites W2065952188 @default.
• W1978183755 cites W2068708514 @default.
• W1978183755 cites W2071164950 @default.
• W1978183755 cites W2073020333 @default.
• W1978183755 cites W2086010515 @default.
• W1978183755 cites W2088501009 @default.
• W1978183755 cites W2093472902 @default.
• W1978183755 cites W2098279377 @default.
• W1978183755 cites W2098378066 @default.
• W1978183755 cites W2103564326 @default.
• W1978183755 cites W2121429936 @default.
• W1978183755 cites W2157166246 @default.
• W1978183755 cites W2267597394 @default.
• W1978183755 cites W2464041558 @default.
• W1978183755 cites W2912584980 @default.
• W1978183755 cites W46242078 @default.
• W1978183755 doi "https://doi.org/10.1200/jco.20.6.1668" @default.
• W1978183755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11896118" @default.
• W1978183755 hasPublicationYear "2002" @default.
• W1978183755 type Work @default.
• W1978183755 sameAs 1978183755 @default.
• W1978183755 citedByCount "219" @default.
• W1978183755 countsByYear W19781837552012 @default.
• W1978183755 countsByYear W19781837552013 @default.
• W1978183755 countsByYear W19781837552014 @default.
• W1978183755 countsByYear W19781837552015 @default.
• W1978183755 countsByYear W19781837552016 @default.
• W1978183755 countsByYear W19781837552017 @default.
• W1978183755 countsByYear W19781837552018 @default.
• W1978183755 countsByYear W19781837552019 @default.
• W1978183755 countsByYear W19781837552020 @default.
• W1978183755 countsByYear W19781837552021 @default.
• W1978183755 countsByYear W19781837552022 @default.
• W1978183755 countsByYear W19781837552023 @default.
• W1978183755 crossrefType "journal-article" @default.
• W1978183755 hasAuthorship W1978183755A5000790552 @default.
• W1978183755 hasAuthorship W1978183755A5016030391 @default.
• W1978183755 hasAuthorship W1978183755A5018396152 @default.
• W1978183755 hasAuthorship W1978183755A5018823440 @default.
• W1978183755 hasAuthorship W1978183755A5032131181 @default.
• W1978183755 hasAuthorship W1978183755A5035278067 @default.
• W1978183755 hasAuthorship W1978183755A5038254746 @default.
• W1978183755 hasAuthorship W1978183755A5064892508 @default.
• W1978183755 hasAuthorship W1978183755A5070651503 @default.
• W1978183755 hasAuthorship W1978183755A5079010924 @default.
• W1978183755 hasConcept C112705442 @default.
• W1978183755 hasConcept C126322002 @default.
• W1978183755 hasConcept C134306372 @default.
• W1978183755 hasConcept C150903083 @default.
• W1978183755 hasConcept C178790620 @default.
• W1978183755 hasConcept C185592680 @default.
• W1978183755 hasConcept C197336794 @default.
• W1978183755 hasConcept C207001950 @default.
• W1978183755 hasConcept C2776694085 @default.
• W1978183755 hasConcept C2777807558 @default.
• W1978183755 hasConcept C2778125326 @default.
• W1978183755 hasConcept C2778496288 @default.
• W1978183755 hasConcept C2781303535 @default.
• W1978183755 hasConcept C2781467277 @default.
• W1978183755 hasConcept C29730261 @default.
• W1978183755 hasConcept C33923547 @default.
• W1978183755 hasConcept C71924100 @default.
• W1978183755 hasConcept C86803240 @default.
• W1978183755 hasConcept C90924648 @default.
• W1978183755 hasConcept C98274493 @default.
• W1978183755 hasConceptScore W1978183755C112705442 @default.
• W1978183755 hasConceptScore W1978183755C126322002 @default.
• W1978183755 hasConceptScore W1978183755C134306372 @default.

• next